Objectionable Microorganisms in Biopharmaceutical Manufacturing
Recorded Webinar | Carl Patterson | From: Mar 10, 2020 - To: Dec 31, 2020
|
This webinar will discuss the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place.
Areas Covered:-
Why Should You Attend?
Objectionable microorganisms are considered if discovered, harmful to the patient. By identifying and controlling these microorganisms and putting the appropriate controls into place early in the pharmaceutical or medical device manufacturing process, problems in the patient can be prevented.
This webinar will review the regulations pertaining to objectionable microorganisms, testing and identifying objectionable microorganisms, and putting appropriate controls into place to prevent harm to the patient. By knowing, where, when, why, and how objectionable microorganisms exist, harmful consequences to the patient can be prevented.
Who Will Benefit?